ISG names Persistent a Rising Star for Digital Transformation in 2020 ISG Provider Lens™ for Healthcare Digital Services report for U.S.
Recognized for expertise in rapidly delivering patient engagement digital services, and leveraging partner ecosystem to build industry specific solutions
SANTA CLARA, Calif. and PUNE, India, April 6, 2021 /PRNewswire/ --
Persistent Systems (BSE: PERSISTENT) (NSE: PERSISTENT) has been placed as a Rising Star for Provider Digital Transformation Services by leading global technology research and advisory firm Information Services Group (ISG), in the 2020 ISG Provider Lens™ report for Healthcare Digital Services report for the U.S.
Companies that receive the Rising Star award have a promising portfolio or the market experience to become a leader, including the required roadmap and adequate focus on key market trends and customer requirements. Rising Stars also have excellent management and understanding of the market.
The 2020 ISG Provider Lens™ for Healthcare Digital Services report analyzes the relevant software vendors/service providers in the global market, based on a multi-phased research and analysis process, and positions these providers based on the ISG Research methodology. The ISG Provider Lens™ provides an objective, data-driven assessment of technology and service providers' strengths and weaknesses, as well as their relative positioning in a given market.
Persistent was recognized for:
- Expertise in delivering patient engagement projects using Salesforce Health Cloud.
- Product development and accelerators that speed time to market for new digital patient services.
- Utilizing its partner ecosystem, including Salesforce, AWS and ClearData to develop industry specific solutions.
Ron Exler, Director and Principal Analyst, ISG Research
"Persistent Systems excels at delivering digital front door and other capabilities to U.S. healthcare providers, especially via the Salesforce Health Cloud, to support digital transformation. Being named a Rising Star in the Healthcare Digital Services Provider Lens report comes on the heels of being named a Leader in the Provider Lens™ for Salesforce Healthcare and builds on Persistent's ISG Star of Excellence™ Awards win in 2020 for achieving the highest cumulative customer experiences score."
Joe Paxton, Senior Vice President, Healthcare & Life Sciences, Persistent Systems
"Persistent has a proven track record of delivering innovative digital transformation engagements for many of the top US Healthcare providers, including academic medical centers, pediatric hospitals and leading health systems. Being named a Rising Star in the ISG Provider Lens™ report is great external validation of expertise leveraging technology to improve patient engagement and outcomes."
ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of world's top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. For more information, visit www.isg-one.com.
With 12,000+ employees around the world, Persistent Systems (BSE & NSE: PERSISTENT) is a global solutions leader that has been delivering digital business acceleration, enterprise modernization and next-generation product engineering to healthcare and life sciences organizations for 30+ years. To learn more about our healthcare and life sciences solutions visit our website.
Forward-looking and Cautionary Statements
For risks and uncertainties relating to forward-looking statements, please visit persistent.com/FLCS
Persistent Systems (Global)
+1 617 633 1635
+91 84249 17719
Upcoming Life Sciences Events
- May 2021
- European Health-tech Innovation Week
- 7th Annual Immuno-Oncology Innovation Forum
- Pharma-Biotech Product & Company Valuation Course
Latest company news
OSE Immunotherapeutics Announces €10.7 Million in Additional Public Funding, via Bpifrance, to Finance Further Development of CoVepiT, its Multi-Target and Multi-Variant COVID-19 Vaccine in Phase 1 Clinical Phase